Isolierte systolische Hypertonie (ISH) – Alt gegen Jung

Zusammenfassung

Die isolierte systolische Hypertonie (ISH) ist definiert als erhöhter systolischer Blutdruck (BD) mit normalen oder niedrigen diastolischen Werten: > 140/< 90 mmHg bei der konventionellen Blutdruckmessung am Oberarm. Lange bekannt ist die ISH als typische Hochdruckform im Alter. Die Bedeutung der systolischen Blutdruckerhöhung bei juveniler Hypertonie hat dagegen erst in letzter Zeit Aufmerksamkeit bekommen. Dank neuer Messverfahren ist eine bessere Differenzierung der beiden sehr verschiedenen Hochdruckformen möglich. Eine große Blutdruckamplitude im Alter ist Ausdruck eines fortgeschrittenen arteriellen Gefäßschadens und bei Jungen Ausdruck einer besonders guten Prognose. Dementsprechend muss die ISH im Alter behandelt werden und bei den Jungen nicht.

Abstract

Isolated systolic hypertension (ISH) is defined as elevated systolic blood pressure (BD) with normal or low diastolic values: > 140/< 90 mmHg in conventional upper arm blood pressure measurement. ISH has long been known as a typical form of high blood pressure in old age. The importance of systolic hypertension in juvenile hypertension, on the other hand, has only recently received attention. Thanks to new measuring methods, a better differentiation between the two very different forms of hypertension is possible. A large blood pressure amplitude in old age is an expression of advanced arterial vascular damage and in young age a particularly good prognosis. Accordingly, ISH must be treated in old age and not in young age.

Schlüsselwörter

Pulswellenanalyse - Therapie - isolierte systolische Hypertonie

Key words

pulse wave analysis - therapy - isolated systolic hypertension

• Literatur

• 1 Kaess B, Rong J, Larson MG. et al. Aortic Stiffness, Blood Pressure Progression, and Incident Hypertension. JAMA 2012; 308: 875-881 doi:10.1001/2012.jama.10503
• 2 Franklin SS, Pio JR, Wong ND. et al. Predictors of new-onset diastolic and systolic hypertension: the Framingham Heart Study. Circulation 2005; 111: 1121-1127
• 3 Avolio AP, Clyde KM, Beard TC. et al. Improved arterial distensibility in normotensive subjects on a low salt diet. Arteriosclerosis 1986; 6: 166-169
• 4 Giallauria F, Milaneschi Y, Tanaka T. et al. Arterial stiffness and vitamin D levels: The Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2012; 97: 3717-3723
• 5 Mayer jr. O, Filipovský J, Seidlerová J. et al. The association between low 25-hydroxyvitamin D and increased aortic stiffness. J Hum Hypertens 2012; 26: 650-655 doi:10.1038/jhh.2011.94
• 6 Chen CH, Nakayama M, Nevo E. et al. Coupled systolic-ventricular and vascular stiffening with age: implications fort pressure regulation and cardiac reserve in the elderly. J Am Coll Cardiol 1998; 32: 1221-1227
• 7 Heffernan KS, Patvardhan EA, Hession M. et al. Elevated augmentation index derived from peripheral arterial tonometry is associated with abnormal ventricular-vascular coupling. Clin Physiol Funct Imaging 2010; 30: 313-317
• 8 Middeke M. Pulswellenanalyse. Dtsch Med Wochenschr 2017; 142: 1461-1465
• 9 Coutinho T, Borlaug BA, Pellikka PA. et al. Sex differences in arterial stiffness and ventricular-arterial interactions. J Am Coll Cardiol 2013; 61: 96-103
• 10 Weber T, Auer J, OʼRourke MF. et al. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation 2004; 109: 184-189
• 11 Safar ME, Lacolley P. Disturbances of macro- and microcirculation: relations with pulse pressure and cardiac organ damage. Am J Physiol Heart Circ Physiol 2007; 293: H1-H7
• 12 Nilsson PM, Boutouyrie P, Laurent S. Vascular aging: a tale of EVA and ADAM in cardiovascular risk assessment and prevention. Hypertension 2009; 54: 3-10
• 13 Middeke M. EVA (Early Vascular Aging) – Übersetzung in den klinischen Alltag. Dtsch Med Wochenschr 2019; 144: 329-333
• 14 Williams B, Mancia G, Spiering W. et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens 2018; 36: 1953-2041 doi:10.1097/HJH.0000000000001940
• 15 Düsing R, Middeke M. Europäische Hypertonie-Leitlinie 2018: Ein Spiegel der schwierigen Datenlage. Dtsch Arztebl 2018; 115: A-1267/B-1070/C-1062
• 16 Williams B, Lacy PS, Thom SM. et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006; 113: 1213-1225
• 17 Middeke M. Zentraler aortaler Blutdruck: Bedeutender Parameter für Diagnostik und Therapie. Dtsch Med Wochenschr 2017; 142: 1430-1436
• 18 OʼRourke MF, Adji A. Guidelines on guidelines: focus on isolated systolic hypertension in youth. J Hypertens 2013; 31: 649-654
• 19 Saladini F, Santonastaso M, Mos L. et al. Isolated systolic hypertension of young-to-middle-age individuals implies a relatively low risk of developing hypertension needing treatment when central blood pressure is low. J Hypertens 2011; 29: 1311-1319
• 20 Saladini F, Fania C, Mos L. et al. Office pulse pressure is a predictor of favorable outcome in young- to middle-aged subjects with stage 1 hypertension. Hypertension 2017; 70: 537-542